Two-year update from KEYNOTE-799: Pembrolizumab plus concurrent chemoradiation therapy (cCRT) for unresectable, locally advanced, stage III NSCLC.

被引：0

作者：

Reck, Martin

Lee, Ki Hyeong

Frost, Nicolaj

Breder, Valeriy Vladimirovich

Kowalski, Dariusz

Levchenko, Evgeny

Reguart, Noemi

Martinez-Marti, Alex

Houghton, Baerin

Paoli, Jean-Baptiste

Safina, Sufiia

Komiya, Takefumi

Sanford, Amy

Liu, Hong

Song, Andrew J.

Keller, Steven M.

Jabbour, Salma K.

机构：

[1] Airway Res Ctr North, German Ctr Lung Res, LungenClin, Grosshansdorf, Germany

[2] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Coll Med, Cheongju, South Korea

[3] Charit Univ Berlin, Dept Infect Dis & Resp Med, Berlin, Germany

[4] Free Univ Berlin, Berlin, Germany

[5] Humboldt Univ, Berlin, Germany

[6] Berlin Inst Hlth, Berlin, Germany

[7] N N Blokhin Russian Canc Res Ctr, Moscow, Russia

[8] Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland

[9] N N Petrov Natl Med Res Ctr Oncol, St Petersburg, Russia

[10] Hosp Clin Barcelona, Dept Med Oncol, Thorac Oncol Unit, IDIBAPS, Barcelona, Spain

[11] Vall Hebron Inst Oncol VHIO, Hosp Univ Vall Hebron, Barcelona, Spain

[12] Mid North Coast Canc Inst, Port Macquarie Base Hosp, Port Macquarie, NSW, Australia

[13] Clin Clairval, Radiotherapie, Marseille, France

[14] Republican Dispensary Tatarstan MoH, Med Oncol, Kazan, Russia

[15] Sunny Buffalo, Div Hematol Oncol, Buffalo, NY USA

[16] Sanford Hlth, Sioux Falls, SD USA

[17] Merck Co Inc, Kenilworth, NJ USA

[18] Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8508

引用

页数：1

共 35 条

[31] First-line nivolumab (NIVO) plus ipilimumab (IPI) plus two cycles of chemotherapy (chemo) versus chemo alone (4 cycles) in patients with advanced non-small cell lung cancer (NSCLC): Two-year update from CheckMate 9LA.
Reck, Martin
Ciuleanu, Tudor-Eliade
Cobo, Manuel
Schenker, Michael
Zurawski, Bogdan
de Menezes, Juliana Janoski
Richardet, Eduardo
Felip, Jaafar Bennouna Enriqueta
Juan-Vidal, Oscar
Alexandru, Aurella
Sakai, Hiroshi
Scherpereel, Arnaud
Lu, Shun
Paz-Ares, Luis G.
Carbone, David Paul
Memaj, Arteid
Marimuthu, Sathiya
Phuong Tran
John, Tom
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[32] Patient-reported outcomes from the phase III, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/ KEYNOTE-A18 Study of pembrolizumab plus concurrent chemoradiotherapy among patients with high-risk, locally advanced cervical cancer
Randall, Leslie
Sukhin, Vladyslav
Colombo, Nicoletta
Korach, Jacob
Matsumoto, Takashi
Lalondrelle, Susan
Vizkeleti, Julia
Samouelian, Vanessa
Salani, Ritu
Salman, Pamela
Nogueira-Rodrigues, Angelica
Ayhan, Ali
Frentzas, Sophia
Cueva, Juan
Kim, Yong-Man
Petru, Edgar
Milla, Dency Pilar
Sehouli, Jalid
Saevets, Valeriya
Yamada, Karin
Li, Kan
Szamreta, Elizabeth
Nguyen, Allison Martin
Pignata, Sandro
Lorusso, Domenica
GYNECOLOGIC ONCOLOGY, 2024, 190 : S9 - S9
[33] INTERIM ANALYSIS OF THE SPANISH LUNG CANCER GROUP (SLCG) RANDOMIZED PHASE II TRIAL OF THORACIC RADIOTHERAPY (RT) CONCURRENT WITH CISPLATIN (P) PLUS ORAL VINORELBINE (OV) OR ETOPOSIDE (E) FOR UNRESECTABLE LOCALLY ADVANCED (LA) STAGE III NON-SMALL CELL LUNG CANCER (NSCLC). (GECP10/02)
Isla, Dolores
De Las Penas, Ramon
Martinez-Banaclocha, Natividad
Massuti, Bartomeu
Angeles Sala, Maria
Bover, Isabel
Marse, Raquel
Insa, Amelia
Moran, Teresa
Artal, Angel
Diz, Pilar
Gomez-Codina, Jose
Laura Ortega, Ana
Gutierrez, Vanesa
Munoz, Jose
Alvarez De Mon, Melchor
Camps, Carlos
Garcia-Gomez, Ramon
Jurado, Jose M.
Ponce-Aix, Santiago
Provencio, Mariano
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S408 - S408
[34] Enlarge-Lung: Two-Year Follow-Up of Real-World Patients with Locally Advanced or Metastatic (Stage IIIB/IV) Squamous and Non-Squamous Non-Small Cell Lung Cancer (NSCLC) from a National, Prospective, Non-Interventional Study (NiS Enlarge) of Nivolumab after Prior Chemotherapy in Germany
Groeschell, Andreas
Schumann, Christian
Guetz, Sylvia
Schulz, Holger
Mueller-Huesmann, Harald
Schulte, Clemens
Liersch, Ruediger
von der Heyde, Eyck
Wuensch, Verena
Sebastian, Martin
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 117 - 118
[35] ENLARGE-Lung: Two-Year Follow-up of Real-World Patients with Locally Advanced or Metastatic (Stage IIIB/IV) Squamous and Non-Squamous Non-Small Cell Lung Cancer (NSCLC) from a National, Prospective, Non-Interventional Study (NIS ENLARGE) of Nivolumab after Prior Chemotherapy in Germany
Guetz, S.
Schumann, C.
Groeschel, M.
Schulte, C.
Schulz, H.
Mueller-Huesmann, H.
Liersch, R.
von der Heyde, E.
Wuensch, V
Sebastian, M.
PNEUMOLOGIE, 2020, 74 : S38 - S38

← 1 2 3 4 →